RECELL
LIVE

Serial Number

86456218

Owner

Avita Medical Ltd.

Attorney

James Cole

Filing Date

Nov 17, 2014

Add to watchlist:

No watchlists yet
View on USPTO

RECELL Trademark

Serial Number: 86456218 • Registration: 5703469

RECELL is a trademark filed by Avita Medical Ltd. on November 17, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Avita Medical Ltd. (8 trademarks)

Level 9, The Quadrant
Perth 6000 , AU

Entity Type: 03

AVITA MEDICAL AMERICAS, LLC (21 trademarks)

28159 AVENUE STANFORD
VALENCIA, CA 91355

Entity Type: 16

AVITA MEDICAL PTY LTD (2 trademarks)

28159 AVENUE STANFORD
VALENCIA, CA 91355

Entity Type: 99

Trademark Details

Filing Date

November 17, 2014

Registration Date

March 19, 2019

Published for Opposition

November 10, 2015

Goods & Services

[ Medical consulting services in the field of regenerative medicine ]

[ Biological and chemical products for use in regenerative medicine for medical and/or aesthetic purposes, namely, biological skin tissue intended for subsequent implantation, skin grafts, biological preparations for the treatment of epithelial burns, wounds, and imperfections, ] chemical reagents for medical purposes, chemical preparations for medical purposes, namely, for treating epithelial burns, wounds, and imperfections; pharmaceutical and medical preparations for the treatment of epithelial burns, wounds, imperfections and other damages; medicaments to assist with the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; epithelium treatment and repair kits, comprised of medicaments to assist with the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa, as well as a drug preparation and delivery system featuring instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium, to be used by clinicians and veterinarians to produce cellular preparations for the treatment of imperfect, wounded or damaged epithelium [ ; bio-compatible medicated skin preparations for treatment of epithelial imperfections, damages, diseases, and wounds, containing biomaterials, namely, enzymatically dissociated suspensions of epithelial cells and optionally additional factors for promoting cell growth, reproduction and/or differentiation; biological skin tissue, namely, reconstituted human epithelial tissues and cells for medical, clinical and/or aesthetic use ]

Education services in the field of regenerative medicine provided through classes, seminars, and training programs; providing training to clinicians and veterinarians in the field of treatment of epithelial burns, wounds, imperfections and other damages, in particular regeneration of imperfect, wounded or damaged epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; training of clinicians and veterinarians in using epithelium treatment and repair kits comprised of a drug preparation and delivery system featuring instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium

Surgical, medical, and veterinary apparatus and instruments for use in regenerative medicine for medical and/or aesthetic purposes; medical system comprising medical apparatus in the nature of a drug preparation and delivery system featuring instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium, for use by clinicians and veterinarians for preparing and delivering a medicament for the treatment of epithelial burns, wounds, imperfections and other damages; medical devices to promote the regeneration of epithelium tissue such as skin, respiratory epithelium, intestinal epithelium, urothelium, and buccal mucosa; epithelium treatment and repair kits comprised of a drug preparation and delivery system featuring medical instruments, warming plates, delivery applicators and substances used for preparing, dissociating and suspending epithelial cells for delivery to the imperfect, wounded or damaged epithelium

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 18, 2025 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 18, 2025 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 18, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 15, 2025 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 24, 2024 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 17, 2024 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 19, 2024 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 19, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 14, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 13, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 12, 2019 SUPC
USE AMENDMENT FILED
Jan 7, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 7, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 13, 2018 EXRA
SOU EXTENSION 5 GRANTED
Jul 12, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 12, 2018 AITU
SOU EXTENSION 5 FILED
Jul 5, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 5, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2018 EXRA
SOU EXTENSION 4 GRANTED
Jan 4, 2018 EX4G
SOU EXTENSION 4 FILED
Jan 4, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 4, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jul 5, 2017 EX3G
SOU EXTENSION 3 FILED
Jul 5, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 7, 2017 EXRA
SOU EXTENSION 2 GRANTED
Jan 5, 2017 EX2G
SOU EXTENSION 2 FILED
Jan 5, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jul 5, 2016 EX1G
SOU EXTENSION 1 FILED
Jul 5, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 5, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 5, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2015 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 7, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 29, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 29, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 29, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 29, 2015 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2015 CRFA
ASSIGNED TO LIE
Sep 18, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 5, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 5, 2015 GNRT
NON-FINAL ACTION WRITTEN
Mar 5, 2015 CNRT
ASSIGNED TO EXAMINER
Mar 4, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Nov 25, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 24, 2014 NWOS
NEW APPLICATION ENTERED
Nov 20, 2014 NWAP